513
Views
17
CrossRef citations to date
0
Altmetric
Research Article

Bevacizumab and Neovascular Age Related Macular Degeneration: Pathogenesis and Treatment

, &
Pages 69-76 | Received 21 Jun 2010, Accepted 30 Nov 2010, Published online: 24 May 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Mohammad Hossein Yazdi, Mohammad Ali Faramarzi, Shekoufeh Nikfar, Khalil Ghasemi Falavarjani & Mohammad Abdollahi. (2015) Ranibizumab and aflibercept for the treatment of wet age-related macular degeneration. Expert Opinion on Biological Therapy 15:9, pages 1349-1358.
Read now
Saba Hashemi, Mohammad Ali Faramarzi, Khalil Ghasemi Falavarjani & Mohammad Abdollahi. (2014) Bevacizumab for choroidal neovascularization secondary to age-related macular degeneration and pathological myopia. Expert Opinion on Biological Therapy 14:12, pages 1837-1848.
Read now

Articles from other publishers (15)

Mateusz Winiarczyk, Dagmara Winiarczyk, Katarzyna Michalak, Kai Kaarniranta, Łukasz Adaszek, Stanisław Winiarczyk & Jerzy Mackiewicz. (2021) Dysregulated Tear Film Proteins in Macular Edema Due to the Neovascular Age-Related Macular Degeneration Are Involved in the Regulation of Protein Clearance, Inflammation, and Neovascularization. Journal of Clinical Medicine 10:14, pages 3060.
Crossref
Richard F. Spaide. 2021. Pathologic Myopia. Pathologic Myopia 271 293 .
Gibrán Alejandro Estúa-Acosta, Rocío Zamora-Ortiz, Beatriz Buentello-Volante, Mariana García-Mejía & Yonathan Garfias. (2019) Neutrophil Extracellular Traps: Current Perspectives in the Eye. Cells 8:9, pages 979.
Crossref
Qingquan Wei, Junling Liu, Qingyu Liu, Chengda Ren, Wenting Cai, Xiuwei Liang, Jing Wen & Jing Yu. (2018) Combination of bevacizumab and photodynamic therapy vs. bevacizumab monotherapy for the treatment of wet age‑related macular degeneration: A meta‑analysis of randomized controlled trials. Experimental and Therapeutic Medicine.
Crossref
Cihan Ünlü, Gurkan Erdogan, Betul Onal Gunay, Esra Kardes, Betul Ilkay Sezgin Akcay & Ahmet Ergin. (2016) Subfoveal choroidal thickness changes after intravitreal bevacizumab injection for neovascular age-related macular degeneration and diabetic macular edema. International Ophthalmology 37:1, pages 147-158.
Crossref
Qader Motarjemizadeh, Naser Samadi Aidenloo & Siamak Sepehri. (2015) A comparative study of different concentrations of topical bevacizumab on the recurrence rate of excised primary pterygium: a short-term follow-up study. International Ophthalmology 36:1, pages 63-71.
Crossref
Patricia Udaondo, David Salom, Salvador García-Delpech & Ángel Cisneros-Lanuza. (2016) Aflibercept as First-Line Therapy in Patients with Treatment-Naïve Neovascular Age-Related Macular Degeneration: Prospective Case Series Analysis in Real-Life Clinical Practice. Ophthalmologica 236:1, pages 29-35.
Crossref
Tomohito Hamazaki & Kei Hamazaki. 2016. Handbook of Lipids in Human Function. Handbook of Lipids in Human Function 483 497 .
Richard F. Spaide. 2014. Pathologic Myopia. Pathologic Myopia 211 230 .
Ingeborg Klaassen, Cornelis J.F. Van Noorden & Reinier O. Schlingemann. (2013) Molecular basis of the inner blood-retinal barrier and its breakdown in diabetic macular edema and other pathological conditions. Progress in Retinal and Eye Research 34, pages 19-48.
Crossref
Daewon Park, Veeral Shah, Britta M. Rauck, Thomas R. Friberg & Yadong Wang. (2013) An Anti-angiogenic Reverse Thermal Gel as a Drug-Delivery System for Age-Related Wet Macular Degeneration. Macromolecular Bioscience 13:4, pages 464-469.
Crossref
Connie J. Chen & Neil M. Bressler. 2013. Ophthalmology and the Ageing Society. Ophthalmology and the Ageing Society 107 125 .
Kishore Cholkar, Aswani Dutt Vadlapudi, Hoang M. Trinh & Ashim K. Mitra. 2014. Ocular Pharmacology and Toxicology. Ocular Pharmacology and Toxicology 91 118 .
Georges M. El-Mollayess, Joanna S. Saadeh & Haytham I. Salti. (2012) Exogenous Endophthalmitis in Diabetic Patients: A Systemic Review. ISRN Ophthalmology 2012, pages 1-7.
Crossref
T. Hamazaki, T. Nagasawa, K. Hamazaki & M. Itomura. (2012) Inhibitory effect of 5,8,11-eicosatrienoic acid on angiogenesis. Prostaglandins, Leukotrienes and Essential Fatty Acids 86:6, pages 221-224.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.